Recruitment

Recruitment Status
Unknown status

Inclusion Criterias

Confirmed COPD defined as post-bronchodilator FEV1/FVC<0.70
Stable residence for duration of 6 month intervention
Has an established longitudinal care provider in Baltimore, MD
...
Confirmed COPD defined as post-bronchodilator FEV1/FVC<0.70
Stable residence for duration of 6 month intervention
Has an established longitudinal care provider in Baltimore, MD
HIV infected

Exclusion Criterias

Failure to present to randomization visit
Age < 18 years
Unable/unwilling to provide informed consent
Failure to present to randomization visit
Age < 18 years
Unable/unwilling to provide informed consent

Summary

Conditions
  • COPD
  • COPD Exacerbation
Type
Interventional
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Diagnostic

Participation Requirements

Age
Between 18 years and 100 years
Gender
Both males and females

Inclusion Criterias

Confirmed COPD defined as post-bronchodilator FEV1/FVC<0.70
Stable residence for duration of 6 month intervention
Has an established longitudinal care provider in Baltimore, MD
...
Confirmed COPD defined as post-bronchodilator FEV1/FVC<0.70
Stable residence for duration of 6 month intervention
Has an established longitudinal care provider in Baltimore, MD
HIV infected

Exclusion Criterias

Failure to present to randomization visit
Age < 18 years
Unable/unwilling to provide informed consent
Failure to present to randomization visit
Age < 18 years
Unable/unwilling to provide informed consent

Locations

Baltimore, Maryland, 21287
Baltimore, Maryland, 21287

Tracking Information

NCT #
NCT01892566
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
  • Principal Investigator: Gregory Kirk, MD MHS Johns Hopkins University
  • Gregory Kirk, MD MHS Johns Hopkins University